Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Diabetes Care|September 29, 2011
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfactionAntonio Nicolucci, Stefano Del Prato, Giacomo Vespasiani, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2022
New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 DiabetesDavid Kerr, Steven Edelman, Giacomo Vespasiani, et al.Diabetes Technology & Therapeutics|October 22, 2011
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR studyStefano Del Prato, Antonio Nicolucci, Augusto C Lovagnini-Scher, et al.Diabetes Research and Clinical Practice|September 23, 2017
Insulin regimens and glycemic control in different parts of Europe over 4years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional studyLawrence Blonde, Michel Marre, Maya Vincent, et al.Acta Diabetologica|February 9, 2024
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registryAntonio Nicolucci, Giusi Graziano, Fortunato Lombardo, et al.Journal of Psychosomatic Research|November 4, 2015
Correlates of diabetes-related distress in type 2 diabetes: Findings from the benchmarking network for clinical and humanistic outcomes in diabetes (BENCH-D) studyBasilio Pintaudi, Giuseppe Lucisano, Sandro Gentile, et al.Journal of Diabetes Science and Technology|January 17, 2019
A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 DiabetesMelanie Davies, Steve Bain, Guillaume Charpentier, et al.Diabetes Technology & Therapeutics|July 13, 2013
Impact of the "Diabetes Interactive Diary" telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetesMaria Chiara Rossi, Antonio Nicolucci, Giuseppe Lucisano, et al.Acta Diabetologica|May 24, 2024
Effectiveness of switching from first-generation basal insulin to Glargine 300 U/mL in children and adolescents with type 1 diabetes: results from the ISPED CARD databaseMaria Chiara Rossi, Riccardo Bonfanti, Giusi Graziano, et al.Pediatric Diabetes|December 1, 2025
Comparative Effectiveness of Switching From First-Generation Basal Insulins to Either Glargine 300 U/mL or Degludec 100 U/mL in Children and Adolescents With Type 1 Diabetes: Results From the ISPED CARD Clinical RegistryIvana Rabbone, Riccardo Bonfanti, Giusi Graziano, et al.Pageof 3